Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

14,200 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Rare TCF3 variants associated with pediatric B cell acute lymphoblastic leukemia.
Miyamoto S, Urayama KY, Arakawa Y, Koh K, Yuza Y, Hasegawa D, Taneyama Y, Noguchi Y, Yanagimachi M, Inukai T, Ota S, Takahashi H, Keino D, Toyama D, Takita J, Tomizawa D, Morio T, Koike K, Moriwaki K, Sato Y, Fujimura J, Morita D, Sekinaka Y, Nakamura K, Sakashita K, Goto H, Manabe A, Takagi M. Miyamoto S, et al. Among authors: takahashi h. Pediatr Hematol Oncol. 2024;41(1):81-87. doi: 10.1080/08880018.2023.2201302. Epub 2023 May 2. Pediatr Hematol Oncol. 2024. PMID: 37129918
Outcomes following induction failure in Japanese children with acute lymphoblastic leukemia.
Imai C, Sato A, Hiwatari M, Shimomura Y, Hori T, Suenobu S, Imamura T, Hara J, Hasegawa D, Takahashi H, Moriya K, Katayama S, Tomizawa D, Moritake H, Taga T, Horibe K, Koh K, Manabe A, Okamoto Y. Imai C, et al. Among authors: takahashi h. Int J Hematol. 2023 Jul;118(1):99-106. doi: 10.1007/s12185-023-03600-3. Epub 2023 Apr 10. Int J Hematol. 2023. PMID: 37037958
Clinical risk factors for patients with myelodysplastic syndromes undergoing allogeneic hematopoietic stem cell transplantation.
Teshigawara-Tanabe H, Hagihara M, Aoki J, Koyama S, Takahashi H, Nakajima Y, Kunimoto H, Tachibana T, Miyazaki T, Matsumoto K, Tanaka M, Yamazaki E, Fujisawa S, Kanamori H, Taguri M, Nakajima H. Teshigawara-Tanabe H, et al. Among authors: takahashi h. Hematology. 2022 Dec;27(1):620-628. doi: 10.1080/16078454.2022.2052601. Hematology. 2022. PMID: 35621915
[Spontaneous remission of primary breast diffuse large B-cell lymphoma].
Nukui J, Takahashi H, Tokunaga M, Suzuki T, Yoshioka E, Yokose T, Nakamura N, Sakai R, Nakajima H. Nukui J, et al. Among authors: takahashi h. Rinsho Ketsueki. 2022;63(11):1491-1496. doi: 10.11406/rinketsu.63.1491. Rinsho Ketsueki. 2022. PMID: 36476786 Japanese.
Clinical practice guidelines for molecular tumor marker, 2nd edition review part 2.
Kikuchi Y, Shimada H, Yamasaki F, Yamashita T, Araki K, Horimoto K, Yajima S, Yashiro M, Yokoi K, Cho H, Ehira T, Nakahara K, Yasuda H, Isobe K, Hayashida T, Hatakeyama S, Akakura K, Aoki D, Nomura H, Tada Y, Yoshimatsu Y, Miyachi H, Takebayashi C, Hanamura I, Takahashi H. Kikuchi Y, et al. Among authors: takahashi h. Int J Clin Oncol. 2024 May;29(5):512-534. doi: 10.1007/s10147-024-02497-0. Epub 2024 Mar 17. Int J Clin Oncol. 2024. PMID: 38493447
Comparison of standardized prophylactic high-dose and intrathecal methotrexate for DLBCL with a high risk of CNS relapse.
Akimoto M, Miyazaki T, Takahashi H, Saigusa Y, Takeda T, Hibino Y, Tokunaga M, Ohashi T, Matsumura A, Teshigawara H, Suzuki T, Teranaka H, Nakajima Y, Matsumoto K, Hashimoto C, Fujimaki K, Fujita H, Sakai R, Fujisawa S, Nakajima H. Akimoto M, et al. Among authors: takahashi h. Int J Hematol. 2024 Feb;119(2):164-172. doi: 10.1007/s12185-023-03700-0. Epub 2024 Jan 17. Int J Hematol. 2024. PMID: 38233702
Characteristics and prognosis of patients with COVID-19 and hematological diseases in Japan: a cross-sectional study.
Minakata D, Uchida T, Nakano A, Takase K, Tsukada N, Kosugi H, Kawata E, Nakane T, Takahashi H, Endo T, Nishiwaki S, Fujiwara H, Saito AM, Saito TI, Akashi K, Matsumura I, Mitani K. Minakata D, et al. Among authors: takahashi h. Int J Hematol. 2024 Feb;119(2):183-195. doi: 10.1007/s12185-023-03685-w. Epub 2024 Jan 3. Int J Hematol. 2024. PMID: 38172385 Free PMC article.
Adverse impact of delay of platelet recovery after autologous hematopoietic cell transplantation for aggressive non-Hodgkin lymphoma and multiple myeloma.
Okada Y, Kimura F, Kurita N, Takahashi H, Shimazu Y, Mizuno S, Uchida N, Kataoka K, Hiramoto N, Ota S, Kako S, Tsukada N, Kanda Y, Kurahashi S, Doki N, Nishikawa A, Kim SW, Hangaishi A, Kanda J, Fukuda T, Atsuta Y, Kondo E, Kawamura K, Nakasone H. Okada Y, et al. Among authors: takahashi h. Cytotherapy. 2023 Nov;25(11):1212-1219. doi: 10.1016/j.jcyt.2023.05.015. Epub 2023 Jun 24. Cytotherapy. 2023. PMID: 37354150
Investigation of biomarkers to predict outcomes in allogeneic hematopoietic stem cell transplantation.
Tachibana T, Miyazaki T, Matsumura A, Hagihara M, Tanaka M, Koyama S, Ogusa E, Aoki J, Nakajima Y, Takahashi H, Suzuki T, Ishii Y, Teshigawara H, Matsumoto K, Hatayama M, Izumi A, Ikuta K, Yamamoto K, Kanamori H, Fujisawa S, Nakajima H. Tachibana T, et al. Among authors: takahashi h. Cytotherapy. 2024 Mar 30:S1465-3249(24)00575-9. doi: 10.1016/j.jcyt.2024.03.490. Online ahead of print. Cytotherapy. 2024. PMID: 38625069
14,200 results
You have reached the last available page of results. Please see the User Guide for more information.